Molecular Partners says 5 of 8 patients responded in multiple myeloma trial

ZURICH (Reuters) - Molecular Partners said on Friday that five of eight patients with advanced multiple myeloma in a Phase II study showed an objective response to a combination therapy that includes an investigational drug from the Swiss company.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news